250 related articles for article (PubMed ID: 10678985)
1. Influence of synthetic antiendotoxin peptides on lipopolysaccharide (LPS) recognition and LPS-induced proinflammatory cytokine responses by cells expressing membrane-bound CD14.
Iwagaki A; Porro M; Pollack M
Infect Immun; 2000 Mar; 68(3):1655-63. PubMed ID: 10678985
[TBL] [Abstract][Full Text] [Related]
2. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids.
Schröder NW; Opitz B; Lamping N; Michelsen KS; Zähringer U; Göbel UB; Schumann RR
J Immunol; 2000 Sep; 165(5):2683-93. PubMed ID: 10946299
[TBL] [Abstract][Full Text] [Related]
3. Dual effects of LPS antibodies on cellular uptake of LPS and LPS-induced proinflammatory functions.
Pollack M; Ohl CA; Golenbock DT; Di Padova F; Wahl LM; Koles NL; Guelde G; Monks BG
J Immunol; 1997 Oct; 159(7):3519-30. PubMed ID: 9317151
[TBL] [Abstract][Full Text] [Related]
4. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
[TBL] [Abstract][Full Text] [Related]
5. Accelerated internalization and detoxification of endotoxin by anti-lipopolysaccharide antibody is an Fc receptor--mediated process.
Lazaron V; Leslie DB; Wasiluk KR; Dunn DL
Surgery; 2001 Aug; 130(2):192-7. PubMed ID: 11490348
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.
Kitchens RL; Ulevitch RJ; Munford RS
J Exp Med; 1992 Aug; 176(2):485-94. PubMed ID: 1380063
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction events in Chinese hamster ovary cells expressing human CD14; effect of endotoxin desensitization.
Ferlito M; Squadrito F; Halushka PV; Cook JA
Shock; 2001 Apr; 15(4):291-6. PubMed ID: 11303728
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes.
Blondin C; Le Dur A; Cholley B; Caroff M; Haeffner-Cavaillon N
Eur J Immunol; 1997 Dec; 27(12):3303-9. PubMed ID: 9464818
[TBL] [Abstract][Full Text] [Related]
9. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.
Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Heumann D
J Immunol; 2001 Sep; 167(6):3329-38. PubMed ID: 11544322
[TBL] [Abstract][Full Text] [Related]
10. CD11/CD18 and CD14 share a common lipid A signaling pathway.
Ingalls RR; Monks BG; Savedra R; Christ WJ; Delude RL; Medvedev AE; Espevik T; Golenbock DT
J Immunol; 1998 Nov; 161(10):5413-20. PubMed ID: 9820516
[TBL] [Abstract][Full Text] [Related]
11. The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent.
Plötz SG; Lentschat A; Behrendt H; Plötz W; Hamann L; Ring J; Rietschel ET; Flad HD; Ulmer AJ
Blood; 2001 Jan; 97(1):235-41. PubMed ID: 11133766
[TBL] [Abstract][Full Text] [Related]
12. Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two distinct mechanisms.
Burd RS; Battafarano RJ; Cody CS; Farber MS; Ratz CA; Dunn DL
Ann Surg; 1993 Sep; 218(3):250-9; discussion 259-61. PubMed ID: 8373268
[TBL] [Abstract][Full Text] [Related]
13. Rough and smooth forms of fluorescein-labelled bacterial endotoxin exhibit CD14/LBP dependent and independent binding that is influencedby endotoxin concentration.
Triantafilou M; Triantafilou K; Fernandez N
Eur J Biochem; 2000 Apr; 267(8):2218-26. PubMed ID: 10759844
[TBL] [Abstract][Full Text] [Related]
14. A region of human CD14 required for lipopolysaccharide binding.
Viriyakosol S; Kirkland TN
J Biol Chem; 1995 Jan; 270(1):361-8. PubMed ID: 7529231
[TBL] [Abstract][Full Text] [Related]
15. Binding specificity of polymyxin B, BPI, LALF, and anti-deep core/lipid a monoclonal antibody to lipopolysaccharide partial structures.
Kellogg TA; Lazaron V; Wasiluk KR; Dunn DL
Shock; 2001 Feb; 15(2):124-9. PubMed ID: 11220640
[TBL] [Abstract][Full Text] [Related]
16. Lipoteichoic acid acts as an antagonist and an agonist of lipopolysaccharide on human gingival fibroblasts and monocytes in a CD14-dependent manner.
Sugawara S; Arakaki R; Rikiishi H; Takada H
Infect Immun; 1999 Apr; 67(4):1623-32. PubMed ID: 10084995
[TBL] [Abstract][Full Text] [Related]
17. Involvement of microbial components and toll-like receptors 2 and 4 in cytokine responses to air pollution particles.
Becker S; Fenton MJ; Soukup JM
Am J Respir Cell Mol Biol; 2002 Nov; 27(5):611-8. PubMed ID: 12397021
[TBL] [Abstract][Full Text] [Related]
18. Polymyxin B antagonizing biological activity of lipopolysaccharide.
Guo YB; Chen LP; Cao HW; Wang N; Zheng J; Xiao GX
Chin J Traumatol; 2007 Jun; 10(3):180-3. PubMed ID: 17535644
[TBL] [Abstract][Full Text] [Related]
19. Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide.
Flo TH; Halaas O; Lien E; Ryan L; Teti G; Golenbock DT; Sundan A; Espevik T
J Immunol; 2000 Feb; 164(4):2064-9. PubMed ID: 10657659
[TBL] [Abstract][Full Text] [Related]
20. IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans.
Verbon A; Dekkers PE; ten Hove T; Hack CE; Pribble JP; Turner T; Souza S; Axtelle T; Hoek FJ; van Deventer SJ; van der Poll T
J Immunol; 2001 Mar; 166(5):3599-605. PubMed ID: 11207321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]